BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3303125)

  • 1. Cefotetan (Cefotan): a new cephalosporin.
    Ahmed ME; May G; Branch RA
    Ration Drug Ther; 1986 Dec; 20(12):1-5. PubMed ID: 3303125
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotetan disodium (Cefotan).
    Med Lett Drugs Ther; 1986 Jul; 28(718):70-2. PubMed ID: 3523182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cefotetan, Apatef].
    Friis H; Moesgaard F
    Ugeskr Laeger; 1987 Aug; 149(36):2408-10. PubMed ID: 3329791
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Sweet R; Ritter M
    Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefotetan: microbiologic, kinetic and clinical aspects].
    Di Nola F; Capra E; Angela GC; Eandi M; Soranzo ML
    G Ital Chemioter; 1984; 31(1-2):101-11. PubMed ID: 6590403
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
    Wilson SE; Boswick JA; Duma RJ; Echols RM; Jemsek JG; Lerner R; Lewis RT; Najem AZ; Press RA; Rittenbury MS
    Am J Surg; 1988 May; 155(5A):61-6. PubMed ID: 3287971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical applications of cefotetan in inernal infections].
    Altucci P; Abbate GF; Alagia I; Giaquinto E; Leonessa V; Nappi R; Papaleo G
    G Ital Chemioter; 1984; 31(1-2):113-20. PubMed ID: 6590404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with rational cefotetan therapy in in situ and associated surgical infections].
    Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G
    Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy].
    Gaillat J; Croize J; Bru JP; Stahl JP; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):461-4. PubMed ID: 3534722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
    Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W
    Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue levels of cefotetan in odonto-stomatological diseases].
    Gismondo MR; Rapisarda E; Lo Bue AM
    G Ital Chemioter; 1985; 32(2):375-7. PubMed ID: 3869117
    [No Abstract]   [Full Text] [Related]  

  • 13. Cefotetan: summary of the symposium from an internist's viewpoint.
    Barza M
    Am J Surg; 1988 May; 155(5A):103-7. PubMed ID: 3163898
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cefotetan in pediatrics].
    Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N
    Jpn J Antibiot; 1983 Jun; 36(6):1185-90. PubMed ID: 6581324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
    Klech H; Fiser I
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244
    [No Abstract]   [Full Text] [Related]  

  • 17. Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
    Wilson SE
    J Chemother; 1989 Jul; 1(4 Suppl):820-2. PubMed ID: 16312655
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
    Saito M; Saito T; Yano K; Shibata K; Nishino T; Tanino T
    J Antimicrob Chemother; 1984 Feb; 13(2):133-42. PubMed ID: 6368517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of cefotetan in clinical practice].
    Vinogradova MA; Kozko TD; Petukhov EM; Shubina VA; Shneĭter II; Miroshina TI; Vinogradov NA; Astaf'eva TA; Astakhova ZN; Bokov IB; Rogovaia KI; Maksimova VI; Petrushina VS; Predtechenskaia TI
    Antibiot Khimioter; 1997; 42(7):16-9. PubMed ID: 9334142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.